GLOW Blend 70MG

The GLOW blend 70MG from Maple Research Labs is a premium multi-peptide research formulation. This GLOW blend 70MG combines GHK-Cu, BPC-157, and TB-500 in a single 70mg vial for comprehensive research protocols. Researchers across Canada choose our GLOW blend 70MG for its published batch certificate and independent third-party testing.

GLOW Blend 70MG Research Compound Overview

GLOW blend 70MG from Maple Research Labs is a multi-peptide research formulation combining GHK-Cu, BPC-157, and TB-500 in a single 70mg vial, with the independent third-party report for the current batch published on this page.

The GLOW Blend is a multi-peptide research formulation combining BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) into a single 70mg lyophilized vial. Developed for in-vitro and preclinical research applications, the GLOW Blend offers investigators a streamlined approach to studying the interplay between tissue remodeling, extracellular matrix regulation, and angiogenic signaling pathways.

Why Choose GLOW blend 70MG from Maple Research

Researchers across Canada choose Maple Research Labs for published batch documentation and same-day shipping on all orders.

GLOW Blend Product Specifications

• CAS Numbers: BPC-157: 137525-51-0 / GHK-Cu: 49557-75-7 / TB-500: 77591-33-4
• Composition: BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg)
• Purity: GHK-Cu 99.73%, BPC-157 99.43% and TB-500 99.39% by HPLC-MS/MS on the current tested sample (report COA-2026-SC-02428, see the certificate below)
• Measured content: 83.33mg total against the 70mg label (GHK-Cu 59.44mg, BPC-157 12.42mg, TB-500 11.47mg)
• Form: Lyophilized powder
• Quantity: 70mg per vial
• Testing: Independent third-party laboratory, batch certificate linked below

GLOW Blend Research Summary

The GLOW Blend combines three peptides that have been individually investigated for their roles in tissue biology. BPC-157, a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein, has been studied in animal models for its effects on vascular endothelial growth factor (VEGF) expression and nitric oxide synthase (NOS) system modulation. Published research has examined BPC-157 in the context of wound healing, tendon repair, and gastrointestinal tissue integrity in rodent models (Sikiric et al., 2010).

GHK-Cu is a naturally occurring copper-binding tripeptide investigated in cell culture models for its influence on collagen synthesis, glycosaminoglycan production, and matrix metalloproteinase (MMP) activity. Research has demonstrated that GHK-Cu modulates gene expression related to tissue remodeling in fibroblast culture systems (Pickart et al., 2014).

TB-500 (Thymosin Beta-4 fragment) has been examined in preclinical research for its role in actin sequestration and cellular migration signaling. Studies in animal models have explored its potential involvement in tissue repair and inflammatory response modulation.

Why Researchers Choose the GLOW Blend

Preclinical research has explored the individual components of the GLOW Blend across distinct but potentially complementary biological pathways. In-vitro studies with BPC-157 have examined its effects on fibroblast migration, endothelial tube formation, and inflammatory cytokine modulation. GHK-Cu has been investigated in keratinocyte and fibroblast culture models for its effects on tissue remodeling gene expression, including elastin, decorin, and various collagen subtypes. TB-500 research in animal models has focused on its interaction with the actin cytoskeleton and its influence on cell motility and differentiation markers.

The GLOW Blend provides researchers with a tool for studying the interplay between angiogenic signaling (BPC-157), extracellular matrix regulation (GHK-Cu), and cytoskeletal dynamics (TB-500) within a single experimental framework. Each component targets distinct molecular pathways, allowing researchers to investigate potential synergistic or additive effects in tissue biology models. This multi-target approach makes the GLOW Blend particularly relevant for laboratories studying wound repair mechanisms, connective tissue biology, and regenerative medicine pathways.

GLOW Blend Purity and Quality Assurance

Each peptide component of the GLOW Blend is synthesized using solid-phase peptide synthesis (SPPS) and purified via reverse-phase high-performance liquid chromatography (RP-HPLC). The blended vial is then submitted to an independent third-party laboratory. The current sample was analyzed by SideChain Analytics in Mississauga, Ontario by HPLC-MS/MS, which quantifies each peptide separately instead of reporting one combined figure: GHK-Cu 59.44 mg at 99.73% chromatographic purity, BPC-157 12.42 mg at 99.43% and TB-500 11.47 mg at 99.39%, for 83.33 mg total net peptide against a 70.00 mg label claim. The full report is linked in the certificate table below. The article on peptide blend COA limits explains why a multi-component vial needs a separate content assay for each peptide and not a single purity number, which is how this certificate is structured.

The batch-specific Certificate of Analysis for the GLOW Blend lot currently shipping is linked on this page and indexed on the Certificates of Analysis page. It includes the HPLC-MS/MS result for each component, measured purity, and fill accuracy against label claim, providing the transparency required for reproducible experimental outcomes. Maple Research Labs publishes independent reports for tested batches across the catalog and lists the compounds still awaiting a certificate on the same page.

Storage and Handling

Store lyophilized peptide at -20°C. Reconstituted solution should be stored at 2-8°C and used within 28 days. Avoid repeated freeze-thaw cycles. The batch certificate for the lot currently shipping is linked on this page for traceability and research reproducibility.

Shipping

Ships same-day from our Canadian facility. All orders include temperature-controlled packaging. The GLOW Blend ships to all provinces across Canada with tracked delivery.

Certificate of Analysis (COA)

Results are for the sample the laboratory received, reported as measured. The original PDF is also served by the laboratory from its own verification page.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

When ordering GLOW blend 70MG from Maple Research Labs, researchers receive a multi-peptide formulation with a published batch certificate. The lot currently shipping was tested by an independent third-party laboratory and the report is linked in the table above.